The effects of modified anti-inflammatory diet on fatigue, quality of life, and inflammatory biomarkers in relapsing-remitting multiple sclerosis patients: a randomized clinical trial

References

• Kasper D, Fauci A, Hauser S, et al. Harrison’s principles of internal medicine. New York: McGraw-Hill Education; 2015.
   Google Scholar
• Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015;15(9):545–558.
   PubMed Web of Science ®Google Scholar
• Lublin FD, Reingold SC, Cohen JA, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83(3):278–286.
   PubMed Web of Science ®Google Scholar
• Dolati S, Babaloo Z, Jadidi-Niaragh F, et al. Multiple sclerosis: Therapeutic applications of advancing drug delivery systems. Biomed Pharmacother Biomed Pharmacother. 2017;86:343–353.
   PubMed Web of Science ®Google Scholar
• Etemadifar M, Izadi S, Nikseresht A, et al. Estimated prevalence and incidence of multiple sclerosis in Iran. Eur Neurol. 2014;72(5-6):370–374.
   PubMed Web of Science ®Google Scholar
• Imitola J, Chitnis T, Khoury SJ. Cytokines in multiple sclerosis: from bench to bedside. Pharmacol Ther. 2005;106(2):163–177.
   PubMed Web of Science ®Google Scholar
• Boppana S, Huang H, Ito K, et al. Immunologic aspects of multiple sclerosis. Mt Sinai J Med. 2011;78(2):207–220.
   PubMedGoogle Scholar
• Kos D, Kerckhofs E, Nagels G, et al. Origin of fatigue in multiple sclerosis: review of the literature. Neurorehabil Neural Repair. 2008;22(1):91–100.
   PubMed Web of Science ®Google Scholar
• Malekzadeh A, Van de Geer-Peeters W, De Groot V, et al. Fatigue in patients with multiple sclerosis: is it related to pro- and anti-inflammatory cytokines? Dis Markers. 2015;2015:1–7.
   Web of Science ®Google Scholar
• Heesen C, Nawrath L, Reich C, et al. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J Neurol Neurosurg Psychiatry. 2006;77(1):34–39.
   PubMed Web of Science ®Google Scholar
• Janardhan V, Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J Neurol Sci. 2002;205(1):51–58.
   PubMed Web of Science ®Google Scholar
• Swank RL, Dugan BB. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet (London, England). 1990;336(8706):37–39.
   PubMed Web of Science ®Google Scholar
• von Geldern G, Mowry EM. The influence of nutritional factors on the prognosis of multiple sclerosis. Nat Rev Neurol. 2012;8(12):678–689.
   PubMed Web of Science ®Google Scholar
• Riccio P. The molecular basis of nutritional intervention in multiple sclerosis: a narrative review. Complement Ther Med. 2011;19(4):228–237.
   PubMed Web of Science ®Google Scholar
• Hadgkiss EJ, Jelinek GA, Weiland TJ, et al. The association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis. Nutr Neurosci. 2015;18(3):125–136.
   PubMed Web of Science ®Google Scholar
• Fitzgerald KC, Tyry T, Salter A, et al. Diet quality is associated with disability and symptom severity in multiple sclerosis. Neurology. 2018;90(1):e1–e11.
   PubMed Web of Science ®Google Scholar
• Moravejolahkami AR, Paknahad Z, Chitsaz A. Association of dietary patterns with systemic inflammation, quality of life, disease severity, relapse rate, severity of fatigue and anthropometric measurements in MS patients. Nutr Neurosci. 2019;1–11.
   PubMed Web of Science ®Google Scholar
• Weinstock-Guttman B, Baier M, Park Y, et al. Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins,Leukot Essent Fatty Acids. 2005;73(5):397–404.
   PubMed Web of Science ®Google Scholar
• Yadav V, Marracci G, Kim E, et al. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial. Multiple Sclerosis Relat Disord. 2016;9:80–90.
   PubMed Web of Science ®Google Scholar
• Riccio P, Rossano R, Larocca M, et al. Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study. Exp Biol Med (Maywood). 2016;241(6):620–635.
   PubMed Web of Science ®Google Scholar
• Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302.
   PubMed Web of Science ®Google Scholar
• Esfahani FH, Asghari G, Mirmiran P, et al. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran Lipid and Glucose Study. J Epidemiol. 2010;20(2):150–158.
   PubMed Web of Science ®Google Scholar
• Mahan LK, Raymond JL. Krause’s food & the nutrition care process. Amsterdam, Netherlands: Elsevier health sciences; 2017.
   Google Scholar
• Pasquinelli S, Solaro C. Nutritional assessment and malnutrition in multiple sclerosis. Neurol Sci. 2008;29(S4):367–369.
   PubMed Web of Science ®Google Scholar
• Shrivastava SR, Shrivastava PS, Ramasamy J. World Health Organization advocates for a healthy diet for all: Global perspective. J Res Med Sci. 2016;21(1):44.
   PubMed Web of Science ®Google Scholar
• Shivappa N, Steck SE, Hurley TG, et al. Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr. 2014;17(8):1689–1696.
   PubMed Web of Science ®Google Scholar
• Shivappa N, Steck SE, Hurley TG, et al. A population-based dietary inflammatory index predicts levels of C-reactive protein in the Seasonal Variation of Blood Cholesterol Study (SEASONS). Public Health Nutr. 2014;17(8):1825–1833.
   PubMed Web of Science ®Google Scholar
• Fischer JS, LaRocca NG, Miller DM, et al. Recent developments in the assessment of quality of life in multiple sclerosis (MS). Mult Scler. 1999;5(4):251–259.
   PubMed Web of Science ®Google Scholar
• Harirchian MH, Nasergivechi S, Maddah M, et al. Evaluation of the Persian version of modified fatigue impact scale in Iranian patients with multiple sclerosis. Iran J Neurol. 2013;12(1):32–34.
   PubMedGoogle Scholar
• Vickrey BG, Hays RD, Harooni R, et al. A health-related quality of life measure for multiple sclerosis. Qual Life Res. 1995;4(3):187–206.
   PubMed Web of Science ®Google Scholar
• Ghaem H, Borhani Haghighi A, Jafari P, et al. Validity and reliability of the Persian version of the multiple sclerosis quality of life questionnaire. Neurol India. 2007;55(4):369–375.
   PubMed Web of Science ®Google Scholar
• Sanoobar M, Dehghan P, Khalili M, et al. Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial. Nutr Neurosci. 2016;19(3):138–143.
   PubMed Web of Science ®Google Scholar
• Irish AK, Erickson CM, Wahls TL, et al. Randomized control trial evaluation of a modified Paleolithic dietary intervention in the treatment of relapsing-remitting multiple sclerosis: a pilot study. DNND. 2017;7:1–18.
   Google Scholar
• Choi IY, Piccio L, Childress P, et al. A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms. Cell Rep. 2016;15(10):2136–2146.
   PubMed Web of Science ®Google Scholar
• Riccio P, Rossano R. Nutrition facts in multiple sclerosis. ASN Neuro. 2015;7(1):175909141456818.
   Web of Science ®Google Scholar
• Garcia-Arellano A, Ramallal R, Ruiz-Canela M, et al. Dietary Inflammatory Index and Incidence of Cardiovascular Disease in the PREDIMED Study. Nutrients. 2015;7(6):4124–4138.
   PubMed Web of Science ®Google Scholar
• Rezapour-Firouzi S, Arefhosseini SR, Farhoudi M, et al. Association of Expanded Disability Status Scale and Cytokines after Intervention with Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple Sclerosis Patients(diamond). BioImpacts BI. 2013;3(1):43–47.
   PubMedGoogle Scholar
• Sanoobar M, Eghtesadi S, Azimi A, et al. Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial. Nutr Neurosci. 2015;18(4):169–176.
   PubMed Web of Science ®Google Scholar
• Urcelay E, Santiago JL, Mas A, et al. Role of interleukin 4 in Spanish multiple sclerosis patients. J Neuroimmunol. 2005;168(1-2):164–167.
   PubMed Web of Science ®Google Scholar
• Mondal S, Pahan K. Cinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T cells: implications for multiple sclerosis therapy. PloS One. 2015;10(1):e0116566.
   PubMed Web of Science ®Google Scholar
• Kebir H, Kreymborg K, Ifergan I, et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med. 2007;13(10):1173–1175.
   PubMed Web of Science ®Google Scholar
• Xie L, Li XK, Takahara S. Curcumin has bright prospects for the treatment of multiple sclerosis. Int Immunopharmacol. 2011;11(3):323–330.
   PubMed Web of Science ®Google Scholar
• Mayr HL, Itsiopoulos C, Tierney AC, et al. Improvement in dietary inflammatory index score after 6-month dietary intervention is associated with reduction in interleukin-6 in patients with coronary heart disease: The AUSMED heart trial. Nutrition Res (New York, NY). 2018;55:108–121.
   PubMed Web of Science ®Google Scholar
• Patel DN, King CA, Bailey SR, et al. Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kappaB and C/EBPbeta activation. J Biol Chem. 2007;282(37):27229–27238.
   PubMed Web of Science ®Google Scholar